FTO is highly expressed in AMLs, enhances leukemic oncogene-mediated cell transformation and leukemogenesis, and inhibits all-trans retinoic-acid-induced AML cell differentiation, through regulating the expression of targets such as ASB2 and RARA by reducing m6A levels in these mRNA transcripts [14]. Here, FTO is linked to acute myeloid leukemia.